tiprankstipranks
Dyne Therapeutics (DYN)
NASDAQ:DYN
US Market

Dyne Therapeutics (DYN) Income Statement

Compare
306 Followers

Dyne Therapeutics Income Statement

Last quarter (Q3 2024), Dyne Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Dyne Therapeutics's net income was $-97.13M. See Dyne Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -2.46M$ -3.35M$ -1.09M$ -700.00K$ -271.00K
Operating Expenses
$ 242.16M$ 170.96M$ 150.03M$ 58.65M$ 13.83M
Depreciation and Amortization
$ 2.46M$ 3.35M$ 1.09M$ 700.00K$ 271.00K
EBITDA
$ -233.48M$ -164.75M$ -148.20M$ -58.34M$ -14.59M
Operating Income
$ -242.16M$ -170.96M$ -150.03M$ -58.65M$ -13.83M
Other Income/Expenses
$ 6.22M$ 2.86M$ 734.00K$ -790.00K$ -1.03M
Pretax Income
$ -235.94M$ -168.10M$ -149.29M$ -59.44M$ -14.86M
Net Income
$ -235.94M$ -165.24M$ -149.28M$ -58.74M$ -13.54M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -3.95$ -3.18$ -2.93$ -4.08$ -0.30
Diluted EPS
$ -3.95$ -3.18$ -2.93$ -4.08$ -0.30
Weighted Average Shares Outstanding
59.68M 51.98M 50.90M 14.40M 45.42M
Weighted Average Shares Outstanding (Diluted)
59.68M 51.98M 50.90M 14.40M 45.42M
Currency in USD

Dyne Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis